Navigation Links
Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials
Date:7/20/2010

NEW YORK, July 20 /PRNewswire/ -- Target Health Inc. and LifeOnKey, Inc. today announced they have joined forces to offer an innovative, web-based information platform that will allow the bio-pharmaceutical and medical device industries to optimize clinical trials, help researchers capture, analyze and assess trial data more efficiently, and bring innovative new medicines and devices to patients. 

Through its partnership with LifeOnKey, Target Health can provide health care companies with an electronic clinical trial record that can manage and monitor the care of clinical trial patients from Phase I through Phase IV post-marketing surveillance.  

By combining Target Health's clinical trial software with LifeOnKey's electronic health records (EHRs), the partnership will give clinicians online access to the most recent medical information for their clinical trial patients, allowing them to efficiently track critical information – from side effects to health improvements, while maintaining the integrity of the clinical trial data.  Meanwhile, patients will gain the ability to follow the progress of the clinical trial through their own patient health record.  

"We are very enthusiastic about building a comprehensive solution that integrates clinical trial software and EHRs – the first offering of its kind for this industry," said Target Health President Dr. Jules Mitchel. "This partnership leverages the deep expertise with clinical trials and information systems within both companies to enhance the efficiency of the drug, biologic and device development process."  

"This partnership clearly highlights the ultimate promise of health information technology," said Dr. Linda Harnevo, CEO of LifeOnKey.  "Through the smart application of information technology, we can help clinicians improve the clinical trial process from end-to-end – from better patient recruitment to more effective patient monitoring once the drug is on the market."  

According to Dr. Mitchel and Dr. Harnevo, the Target Health-LifeOnKey partnership will also ensure better compliance with clinical trial requirements and help medical researchers track specific patient groups, follow product use and evaluate patient outcomes over the long term.

About Target Health Inc.

Target Health, established in 1993, is a full-service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, comprising, but not limited to, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, EDC utilizing Target e*CRF®, and Medical Writing. Target Health has developed a full suite of eClinical Trial software including Target e*CRF® (EDC plus randomization and batch edit checks); Target e*CTMS™; Target Document®; (paperless TMF and beyond); Target Encoder® (for MedDRA and WHO Drug); and Target Newsletter®.  Target Health's Pharmaceutical Advisory Dream Team assists companies in strategic planning from Discovery to Market Launch.

www.targethealth.com

About LifeOnKey, Inc.

LifeOnKey is a leader in personalized health technology solutions.  LifeOnKey transforms the way health information is collected, managed and analyzed by major health care stakeholders and used by individuals to improve wellness and self-care.  LifeOnKey's three primary applications – an electronic health record (EHR), a personal health record (PHR) and a Research Center – are seamlessly integrated, delivering relevant data that can be targeted to the needs of each unique user.  The company currently has 1.5 million patient users globally.  LifeOnKey's headquarters are located in New York and its R&D in Herzliya, Israel.

www.lifeonkey.com


'/>"/>
SOURCE Target Health Inc.; LifeOnKey, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Havels Incorporated Announces the Release of Four New Innovative Ultrasound Needles
2. US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others
3. OvaGene Oncology Opens New Innovative Gynecologic Cancer Laboratory and Research Facility
4. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
5. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
6. Seventh Annual Healthcare Unbound Conference Features Innovative Applications of Remote Monitoring, Home Telehealth, mHealth, Social Media and eHealth to Manage Diseases and Promote Wellness
7. Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers
8. DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
9. Henry Schein Announces the Launch of Innovative Henry Schein ConnectHealth(TM) Collaborative
10. I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
11. Innovative University of Cincinnati Program Trains Next Generation of Pharmaceutical Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - ... Medical Devices sector report, "Aesthetic Devices - Medical Devices ... currently in pipeline stage. This report ... and primary research by GlobalData,s team of industry experts. ... removed or altered based on the availability and relevance ...
(Date:2/8/2016)... SAN DIEGO , Feb. 8, 2016  Neurocrine ... the Company will report its fourth quarter and year-end ...  February 11, 2016.  Neurocrine will then host a live ... and provide a Company update Thursday afternoon, February 11, ... Time). http://www.neurocrine.com . --> http://www.neurocrine.com ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016   GS1 ... healthcare professionals to guide them through GS1 Standards implementation ... Drug Administration (FDA) Unique Device Identification (UDI) rule. ... GS1 US; Beth Gibson , senior director industry ... , industry development director, GS1 US --> ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now ... country. The AutismOne 2016 Conference, which is being held May 25-29 at the Loews ... elsewhere about helpful interventions and causes of chronic illness in children. , Very recent ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
Breaking Medicine News(10 mins):